Green Valley Drugs Recalls Magnesium Sulfate Injection Due to Sterility Concerns
Green Valley Drugs is recalling 529 vials of Magnesium Sulfate Injection because the pharmacy could not ensure the products were sterile.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance in injectable drugs, which poses a significant risk of serious injury or death from infection, meeting the criteria for a Severe rating.
Plain-English summary
FVS Holdings, Inc. dba. Green Valley Drugs is recalling 529 vials of Magnesium Sulfate Injection, including various strengths and presentations such as Magnesium Sulfate 50%, MAGNESIUM SULFATE 50% 50 mL, and Magnesium Sulfate PF 50% 2 mL. The recall is being conducted because the compounding pharmacy lacked assurance of sterility for all sterile products it compounded, repackaged, and distributed, along with concerns regarding its quality control processes.
The affected products were distributed nationwide. Specific lot numbers and expiration dates are listed in the recall documentation, including lots expiring between April 2013 and July 2013.
Consumers and healthcare providers should stop using the affected products and contact the recalling firm or their healthcare provider for further instructions.
The recalled product
- Product
- Magnesium Sulfate Injection, all strengths and all presentations including a) Magnesium Sulfate 50%; b) MAGNESIUM SULFATE 50% 50 mL, c) Magnesium Sulfate PF 50% 2 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.
- Manufacturer
- FVS Holdings, Inc. dba. Green Valley Drugs
- Category
- Drug — Injectable
- Affected units
- 529
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- Lot #: a) Magnesium Sulfate 50%: 20130130-F
- Exp 4/30/2013
- 20130128-F
- Exp 4/28/2013
- 20130221-T
- Exp 5/21/2013
- b) MAGNESIUM SULFATE 50% 50 mL: 20130322-E
- Exp 6/22/2013
- 20130219-C
- Exp 5/19/2013
- 20130307-A
- Exp 6/7/2013
- 20130404-G
- Exp 7/4/2013
- c) Magnesium Sulfate PF 50% 2 mL: 20130227-F
- Exp 5/27/2013
- 20130312-G
- Exp 6/12/2013
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 78 recalled by FVS Holdings, Inc. dba. Green Valley Drugs under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 78 products in this recall →Related recalls
Same manufacturer · FVS Holdings, Inc. dba. Green Valley Drugs
See all →- SevereGreen Valley Drugs Recalls Alpha Lipoic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Phosphatidylcholine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereFDA Recalls Acetylcysteine Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Thiamine Hydrochloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Folic Acid Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29